Cargando…
Symptom Diary–Based Analysis of Disease Course among Patients with Mild Coronavirus Disease, Germany, 2020
Limited information is available on the clinical course of outpatients with mild coronavirus disease (COVID-19). This information is critically important to inform public health prevention strategies and to provide anticipatory guidance to patients, primary care providers, and employers. We retrospe...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084503/ https://www.ncbi.nlm.nih.gov/pubmed/33900166 http://dx.doi.org/10.3201/eid2705.204507 |
_version_ | 1783686165561344000 |
---|---|
author | Wiegele, Patricia Nicole Kabar, Iyad Kerschke, Laura Froemmel, Christopher Hüsing-Kabar, Anna Schmidt, Hartmut Vorona, Elena Vollenberg, Richard Tepasse, Phil-Robin |
author_facet | Wiegele, Patricia Nicole Kabar, Iyad Kerschke, Laura Froemmel, Christopher Hüsing-Kabar, Anna Schmidt, Hartmut Vorona, Elena Vollenberg, Richard Tepasse, Phil-Robin |
author_sort | Wiegele, Patricia Nicole |
collection | PubMed |
description | Limited information is available on the clinical course of outpatients with mild coronavirus disease (COVID-19). This information is critically important to inform public health prevention strategies and to provide anticipatory guidance to patients, primary care providers, and employers. We retrospectively assessed the daily prevalence of symptoms in 313 COVID-19 outpatients for the first 20 days of illness. Generalized estimating equations were used to assess the probability of symptom occurrence over time. Fatigue (91%), cough (85%), and headache (78%) were the most common symptoms and occurred a median of 1 day from symptom onset. Neurologic symptoms, such as loss of taste (66%) and anosmia (62%), and dyspnea (51%) occurred considerably later (median 3–4 days after symptom onset). Symptoms of COVID-19 are similar to those of other respiratory pathogens, so symptomatic patients should be tested more frequently for severe acute respiratory syndrome coronavirus 2 during influenza season to prevent further spread of COVID-19. |
format | Online Article Text |
id | pubmed-8084503 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-80845032021-05-11 Symptom Diary–Based Analysis of Disease Course among Patients with Mild Coronavirus Disease, Germany, 2020 Wiegele, Patricia Nicole Kabar, Iyad Kerschke, Laura Froemmel, Christopher Hüsing-Kabar, Anna Schmidt, Hartmut Vorona, Elena Vollenberg, Richard Tepasse, Phil-Robin Emerg Infect Dis Research Limited information is available on the clinical course of outpatients with mild coronavirus disease (COVID-19). This information is critically important to inform public health prevention strategies and to provide anticipatory guidance to patients, primary care providers, and employers. We retrospectively assessed the daily prevalence of symptoms in 313 COVID-19 outpatients for the first 20 days of illness. Generalized estimating equations were used to assess the probability of symptom occurrence over time. Fatigue (91%), cough (85%), and headache (78%) were the most common symptoms and occurred a median of 1 day from symptom onset. Neurologic symptoms, such as loss of taste (66%) and anosmia (62%), and dyspnea (51%) occurred considerably later (median 3–4 days after symptom onset). Symptoms of COVID-19 are similar to those of other respiratory pathogens, so symptomatic patients should be tested more frequently for severe acute respiratory syndrome coronavirus 2 during influenza season to prevent further spread of COVID-19. Centers for Disease Control and Prevention 2021-05 /pmc/articles/PMC8084503/ /pubmed/33900166 http://dx.doi.org/10.3201/eid2705.204507 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Wiegele, Patricia Nicole Kabar, Iyad Kerschke, Laura Froemmel, Christopher Hüsing-Kabar, Anna Schmidt, Hartmut Vorona, Elena Vollenberg, Richard Tepasse, Phil-Robin Symptom Diary–Based Analysis of Disease Course among Patients with Mild Coronavirus Disease, Germany, 2020 |
title | Symptom Diary–Based Analysis of Disease Course among Patients with Mild Coronavirus Disease, Germany, 2020 |
title_full | Symptom Diary–Based Analysis of Disease Course among Patients with Mild Coronavirus Disease, Germany, 2020 |
title_fullStr | Symptom Diary–Based Analysis of Disease Course among Patients with Mild Coronavirus Disease, Germany, 2020 |
title_full_unstemmed | Symptom Diary–Based Analysis of Disease Course among Patients with Mild Coronavirus Disease, Germany, 2020 |
title_short | Symptom Diary–Based Analysis of Disease Course among Patients with Mild Coronavirus Disease, Germany, 2020 |
title_sort | symptom diary–based analysis of disease course among patients with mild coronavirus disease, germany, 2020 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084503/ https://www.ncbi.nlm.nih.gov/pubmed/33900166 http://dx.doi.org/10.3201/eid2705.204507 |
work_keys_str_mv | AT wiegelepatricianicole symptomdiarybasedanalysisofdiseasecourseamongpatientswithmildcoronavirusdiseasegermany2020 AT kabariyad symptomdiarybasedanalysisofdiseasecourseamongpatientswithmildcoronavirusdiseasegermany2020 AT kerschkelaura symptomdiarybasedanalysisofdiseasecourseamongpatientswithmildcoronavirusdiseasegermany2020 AT froemmelchristopher symptomdiarybasedanalysisofdiseasecourseamongpatientswithmildcoronavirusdiseasegermany2020 AT husingkabaranna symptomdiarybasedanalysisofdiseasecourseamongpatientswithmildcoronavirusdiseasegermany2020 AT schmidthartmut symptomdiarybasedanalysisofdiseasecourseamongpatientswithmildcoronavirusdiseasegermany2020 AT voronaelena symptomdiarybasedanalysisofdiseasecourseamongpatientswithmildcoronavirusdiseasegermany2020 AT vollenbergrichard symptomdiarybasedanalysisofdiseasecourseamongpatientswithmildcoronavirusdiseasegermany2020 AT tepassephilrobin symptomdiarybasedanalysisofdiseasecourseamongpatientswithmildcoronavirusdiseasegermany2020 |